POSTER
GENOMICS AND
PROTEOMICS INVESTIGATION ON BLOOD CELLS FROM SCHIZOPHRENIA PATENTS
P.
Sudhakaran1,2, M. Ryan1,2, and S. Bahn1,2
1Department of
Neurobiology, Babraham Institute, Cambridge CB2 4AT, UK; 2Department
of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2
2QQ, UK
The
etiology and pathophysiological abnormalities associated with schizophrenia
remain largely unknown and diagnostic approaches to the disorder are currently
slow, subjective and symptom-based. The aim of our study is to identify
peripheral markers of the disease in blood cells from schizophrenia patients and
to investigate potential immunological disturbances associated with the
disease. We are currently isolating T-cells (CD3-positive selection) from
schizophrenia patients and controls using FACS analysis and employing high
throughput microarray screening to identify differential gene expression between
schizophrenia and control samples. Although we have encouraging preliminary
data, we are still in the process of optimizing the experimental approach and we
are trying to improve on the purity of the isolated cell populations.
Additionally we are employing high throughput 2D gel proteomic investigation for
differential protein expression in erythrocytes. The hope is to compare and
correlate results from peripheral studies with those obtained from our brain
studies in order to explore a potential systemic/peripheral component to the
disorder which would also aid in the development of diagnostic tools.
This work was supported
through a centre grant by the Stanley Medical Research Institute